Indivior shares tank after U.S. indictment for illegal marketing

by on April 11, 2019

Shares of Indivior Plc sank 44 percent on Wednesday after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the film version of its blockbuster opioid addiction treatment Suboxone. (Source: Reuters: Health)

Previous post: